Top compounds associated with response to ABHD11


Feature Type Standardized
Nominal ANOVA
mRNA RAF265 CCLE pan-cancer AAC -0.22 8e-05
mRNA lapatinib CCLE pan-cancer AAC 0.19 9e-05
mRNA TAE684 CCLE pan-cancer AAC -0.16 0.001
mRNA TKI258 CCLE pan-cancer AAC -0.15 0.003
mRNA Sorafenib CCLE pan-cancer AAC -0.084 0.1
mRNA Erlotinib CCLE pan-cancer AAC 0.081 0.1
mRNA Topotecan CCLE pan-cancer AAC -0.066 0.2
mRNA L-685458 CCLE pan-cancer AAC -0.066 0.2
mRNA PD-0332991 CCLE pan-cancer AAC -0.066 0.2
mRNA Crizotinib CCLE pan-cancer AAC -0.056 0.3
Download CSV